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Purpose: To investigate the efficacy and safety of cationic nano-copolymers CS-g-(PEI-b-mPEG) mediated IκB kinase
beta (IKKβ) targeting siRNA in modulating wound healing in a monkey model of glaucoma filtration surgery.
Methods: The IKKβ targeting siRNAs were chemically synthesized and screened in cultured monkey Tenon’s fibroblasts
in vitro. Fourteen monkeys underwent trabeculectomy and were randomly allocated to one of three treatment regimens:
subconjunctival injection of either CS-g-(PEI-b-mPEG)/IKKβ-siRNA (six eyes, 50nM, at the time of surgery and 7 days
post surgery) or phosphate buffered saline (four eyes), or treated with mitomycin C (MMC; four eyes, 0.2 mg/ml). Bleb
survival and characteristics, and intraocular pressure, were evaluated over a 60-day period. Histology of the surgical eyes
was performed to evaluate ocular scarring and fibrosis in each group.
Results: Subconjunctival injection of CS-g-(PEI-b-mPEG)/IKKβ-siRNA was well tolerated in this model. Both siRNA
and MMC significantly prolonged bleb survival compared with the PBS group (the medians for survival days were 45.5,
60, and 29.5 in the siRNA, MMC, and PBS groups, respectively, p<0.01). Higher blebs were observed in the siRNA group
than in the PBS group (p<0.01), while the MMC group showed the highest blebs among three groups (p<0.01). The surgical
eyes in both the siRNA and MMC groups had significantly larger bleb area compared with the PBS group (p<0.01), but
there was no significant difference between the siRNA and MMC groups (p=0.214). There were no significant differences
in IOP readings among the three groups on the designated days after surgery (all p>0.05). The histologic examination
demonstrated that the eyes treated with siRNA showed a marked reduction in subconjunctival scar tissue compared with
the eyes in the PBS group. The conjunctival epithelium appeared healthy without the acellularity that was present in the
MMC group.
Conclusions: Subconjunctival injection of cationic nano-copolymers mediated IKKβ targeting siRNA is associated with
improved surgical outcome in a monkey model of trabeculectomy. This novel approach may potentially be a more
controlled alternative as an anti-scarring agent in glaucoma filtration surgery.
The most common reason for glaucoma filtration surgery
failures is the excessive subconjunctival scarring at the bleb
and  sclerostomy  sites  [1].  The  introduction  of  the
antimetabolites (e.g., mitomycin C [MMC] and 5-fluorouracil
[5-FU]), has considerably improved the outcome of glaucoma
filtration  surgery  in  high-risk  patients.  However,  they  are
relatively  nonspecific  and  may  be  associated  with  an
increased incidence of sight-threatening complications, such
as either bleb leaks or endophthalmitis [2-4]. The challenge
continues to be to develop a safe and effective method for
modulating  the  wound  healing  process  after  glaucoma
filtration surgery.
Nuclear  factor  kappa  B  (NF-κB)  is  an  evolutionarily
conserved family of DNA binding proteins that play a critical
Correspondence to: Jian Ge, M.D., Ph.D., State Key Laboratory of
Ophthalmology,  Zhongshan  Ophthalmic  Center,  Sun  Yat-sen
University, 54 S. Xianlie Rd, Guangzhou 510060 P.R. China; Phone:
86-20-8733-1374;  FAX:  86-20-8733-3271  email:
gejian@mail.sysu.edu.cn
role in the regulation of genes involved in a variety of cellular
processes  [5].  They  exist  in  cytoplasmic  complexes  with
inhibitory proteins of the IκB family, and translocate to the
nucleus to act as transcription factors when activated. IKKβ/
IKBKB  (IκB  kinase  beta),  named  after  its  function  of
phosphorylating IκB molecules, is the crucial kinase of the
IKK-signalosome for activation of NF-κB by inflammatory
stimuli,  which  is  considered  the  classical  (or  canonical)
pathway of NF-κB activation [6,7]. NF-κB has proven to be
a ubiquitous factor associated with wound healing through the
factor’s ability to stimulate transcription of various genes
involved  in  the  activation  of  inflammation  and  cell
proliferation [8,9]. Given the central role of IKKβ in the NF-
κB  pathway,  it  may  be  assumed  that  pharmacological
suppression  of  IKKβ,  and  subsequent  blocking  NF-κB
activity, would be beneficial during the modulation of wound
healing following glaucoma filtration surgery.
RNA interference (RNAi) was originally recognized as
an  evolutionary  conserved  defense  mechanism  in  higher
eukaryotic cells, and this system can easily and effectively
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2502inhibit the expression of one specific gene [10]. Recently,
RNAi-mediated  gene  silencing  has  also  demonstrated
efficiency  in  mammalian  cells,  and  this  has  led  to  the
increasing feasibility of RNAi technology for the therapy of
certain  human  diseases  [11].  In  a  previous  in  vitro  study
[12],  we  determined  the  effects  of  IKKβ  inhibition  using
RNAi  technology  on  human  Tenon’s  fibroblasts  (HTFs),
which have a central role in the scarring process and filtration
bleb failure. The small interfering RNA (siRNA) targeting
IKKβ (IKKβ-siRNA) was designed and delivered into HTFs
using a newly synthesized, ternary cationic copolymer called
CS-g-(PEI-b-mPEG) as the vehicle. The results showed that
the expression of IKKβ was downregulated, and the activation
of  NF-κB  in  the  HTFs  was  subsequently  inhibited.  The
proliferation of HTFs was effectively suppressed through the
blocking of the NF-κB pathway. Furthermore, the non-viral
siRNA  carrier  has  indicated  good  biocompatibility,
biodegradability, and transfection efficiency in vitro.
The purpose of this study was to investigate the effects
of CS-g-(PEI-b-mPEG) mediated IKKβ targeting siRNA on
the ocular wound healing process in a non-human primate
model of filtration surgery, as well as to assess the safety and
tolerance of this CS-g-(PEI-b-mPEG)/IKKβ-siRNA complex
in vivo.
METHODS
IKKβ-siRNA,  CS-g-(PEI-b-mPEG),  and  CS-g-(PEI-b-
mPEG)/IKKβ-siRNA complex: Three pairs of siRNA, which
specifically targeted IKKβ (IKKβ-siRNA) were chemically
synthesized  by  Ribobio  Co.  Ltd.  (Guangzhou,  China).
siRNAs were derived from the coding sequence of the Rhesus
Monkey  (Macaca  mulatta)  IKKβ  gene  (GenBank
XM_001096913), and were designed using an siRNA Target
Finder program. A BLAST search checked all of the duplex
sequences and target sequences of these siRNAs to preclude
sequences with significant similarity to other genes in the
Macaca mulatta genome. The duplex sequences of IKKβ-
siRNA1, IKKβ-siRNA2, and IKKβ-siRNA3 were: 5′-GAA
CAG AGG UUA AUA CAC AdT dT-3′ and 3′-dTd TCU
UGU CUC CAA UUA UGU GU-5′, 5′-GAG CUG UAC
AGG AGA CUA AdT dT-3′ and 3′-dTd TCU CGA CAU
GUC CUC UGA UU-5′, and 5′-CCA AGA AGA GUG AAG
AAC UdT dT-3′ and 3′-dTd TGG UUC UUC UCA CUU
CUU GA −5′, respectively. The non-viral siRNA carrier, CS-
g-(PEI-b-mPEG),  and  CS-g-(PEI-b-mPEG)/IKKβ-siRNA
complex, were synthesized as previously described [12].
In our primary experiments, we found that IKKβ-siRNA2
(5′-GAG CUG UAC AGG AGA CUA AdT dT-3′ and 3′-dTd
TCU  CGA  CAU  GUC  CUC  UGA  UU-5′)  was  the  most
effective  among  the  three  siRNAs  in  downregulating  the
transcription of IKKβ mRNA (data not shown). Therefore, we
used IKKβ-siRNA2 as IKKβ-siRNA in the subsequent RNAi
procedures.
In vitro transfection and assays: Tissue explants of the rhesus
monkey Tenon’s capsule were obtained from two monkeys
(with  no  topical  eye  treatment).  Tenon’s  fibroblasts  were
cultured by a previously reported method [12], as described
below. Cells were maintained as a monolayer at 37 °C with
5%  CO2,  95%  humidified  atmosphere  in  DMEM
supplemented with 10% FBS, 2 mM of L-glutamine, 100 IU/
ml of penicillin, 100 μg/ml of streptomycin, and 25 μg/ml of
amphotericin B. Cells between passages 3 and 6 were used for
the following experiments.
Tenon’s fibroblasts were plated in six well plates with a
density of 6x105 cells per well, and incubated for either 12 h
or 24 h (reaching 60%–70% confluence). Subsequently, the
culture media were replaced with serum- and antibiotic-free
DMEM 2 h before transfection. CS-g-(PEI-b-mPEG)/IKKβ-
siRNA complexes were prepared, at an N/P ratio of 10, 30 min
before transfection (based on our previous results), and cells
were incubated with serum- and antibiotic-free DMEM that
contained complexes corresponding to the determined final
concentrations of IKKβ-siRNA (5, 10, 25, 50, and 100 nM)
for 6 h. Then, the cells were maintained in the serum-supplied
DMEM for either another 24 h or 48 h before the following
assays were performed. Real-time RT–PCR, western blot, and
cell proliferation assay were performed using the previously
reported method [12]. Non-transfected fibroblasts and cells
transfected with 100 nM of scrambled siRNA were regarded
as the controls.
In vivo studies:
Animals—A total of 14 rhesus monkeys that weighed
between 2 to 3 kg, and ranged in age from 3 to 4 years, were
used in this study. A standard ophthalmologic evaluation was
performed  to  exclude  eye  diseases.  Experiments  were
conducted in accordance with the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research.
Filtration  surgery—Surgery  was  performed  under
general anesthesia with intramuscular injection of ketamine
and local anesthesia with 0.5% proparacaine hydrochloride
drops. Conventional trabeculectomy was performed in the
superior  quadrant.  Briefly,  after  a  lid  speculum  was
positioned, a superior rectus bridle suture was used to rotate
the  eye  inferiorly.  A  half-thickness,  rectangular,  3x4-mm
scleral flap was prepared after a limbus-based conjunctival
flap was fashioned. A 1x2-mm sclerostomy was followed by
peripheral iridectomy. The scleral flap was closed with two
10–0 nylon sutures at each corner. The conjunctiva was closed
with a continuous locking suture. Antibiotics and steroids
were  applied  topically  after  surgery.  The  surgery  was
executed by the same masked individual.
Treatment  regimen—The  animals  were  randomly
allocated to one of three treatment regimens: subconjunctival
injection  of  either  CS-g-(PEI-b-mPEG)/IKKβ-siRNA  (six
eyes) or phosphate buffered saline (PBS; four eyes), or treated
with MMC (four eyes). In the IKKβ-siRNA group, 0.1ml of
CS-g-(PEI-b-mPEG)/IKKβ-siRNA (dissolved in RNase-free
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2503H2O, 50 nM concentration) was injected subconjunctivally
into the bleb area by a 30-gauge needle, after the conjunctiva
was closed at the time of surgery. The needle was placed 5 mm
behind the limbus, at the nasal margin of the superior rectus
muscle. The subconjunctival injection was repeated on day 7
after surgery, under general and topical anesthesia. A similar
volume of PBS was administered in the same manner as the
negative control. The MMC group was used as the positive
control.  Eyes  were  treated  at  the  time  of  surgery  with  a
solution  of  0.2  mg/ml  MMC,  using  a  section  of  soaked
microsponge, which was placed between the conjunctiva and
sclera over the determined filtration site for 5 min. The area
was then thoroughly irrigated with physiologic saline.
Clinical observations—The slit-lamp observations were
performed twice per week for the first four weeks, and once
per week thereafter, until the animals were executed on day
60 to assess the conjunctival hyperemia, corneal edema, either
intraocular  inflammation  or  hemorrhage,  and  anterior
chamber depth. The eyes were also stained with fluorescein
to look for evidence of either corneal epithelial toxicity or bleb
leak.  Corneal  endothelial  cell  density  was  examined
preoperatively and 1 month after surgery. Bleb characteristics,
including length and width, were measured with calipers, and
height  was  graded  semiquantitatively  by  slit-lamp
examinations (0, flat; 1, shallow/formed <1 mm; 2, elevated
<2 mm; 3, high >2 mm). Bleb failure was defined as the
appearance of a flat, vascularized, scarred bleb in association
with a deep anterior chamber. Intraocular pressure (IOP) was
measured (average of three consecutive readings) at the same
time  intervals  using  an  applanation  tonometer  (Tonopen;
Reichert, Inc., Depew, NY). All experimental procedures and
analyses were conducted by the same masked investigator.
Histologic analysis—Two monkeys in each group were
killed on day 60. The eyes were enucleated and prepared for
histological examination by conventional optical microscopy.
Serial sections were cut through the sclerostomy site, and
stained with standard hematoxylin-eosin.
Figure  1.  IKKβ-siRNA  inhibits  the
expression of IKKβ at both the mRNA
and protein levels in vitro. A: mRNA
transcription  of  IKKβ  in  monkey
Tenon’s  fibroblasts  assessed  by  real-
time  RT–PCR  24  h  after  5–100  nM
IKKβ-siRNA  were  transfected.  The
normalized  IKKβ  mRNA  level  of
nontransfected  fibroblasts  (control)  is
taken  as  1.0  (the  asterisk  indicates  a
p<0.05,  mean±SD,  n=3).  B:  Protein
levels  of  IKKβ  are  demonstrated  by
western blot.
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2504Statistical analysis: The statistical analyses were conducted
using SPSS version 13.0 for Windows (SPSS Inc., Chicago,
IL). The in vitro results were analyzed by Student's t-test.
Survival analysis was performed for bleb failure using the
Kaplan–Meier log rank test. The area and height of the bleb
were analyzed with a generalized linear model (GLM; SPSS
13.0)  repeated-measures  procedure  to  compare  the  two
groups. IOP measurements were compared among groups




Downregulating  effect  on  IKKβ  expression—Real-
time PCR assay revealed that mRNA transcription of IKKβ in
monkey  Tenon’s  fibroblasts  was  suppressed  in  a  dose-
dependent manner 24 h after 5 to 100 nM of IKKβ-siRNA
were transfected (Figure 1A). Significant inhibition (26%)
was detected following transfection of 10 nM of IKKβ-siRNA
compared  to  the  control  group  (p<0.05),  and  maximum
suppression (51%) was observed in the group transfected with
50 nM of IKKβ-siRNA. Meanwhile, the expression of IKKβ
protein was also inhibited in a dose-dependent manner after
IKKβ-siRNA transfection into the fibroblasts. Alternatively,
no  significant  difference  was  found  in  the  expression  of
GAPDH between the control group and groups transfected
with IKKβ-siRNA (Figure 1B).
Inhibiting  the  proliferation  of  monkey  Tenon’s
fibroblasts—The RNAi process that targets IKKβ repressed
the proliferation of monkey Tenon’s fibroblasts in an siRNA
dose-dependent manner in vitro. The cell viability of Tenon’s
fibroblasts transfected with more than 25 nM of IKKβ-siRNA
showed significant differences compared with those of the
control group (p<0.05), as shown in Figure 2. However, the
proliferation of Tenon’s fibroblasts transfected with 100 nM
of scrambled siRNA was not affected.
In vivo studies: Surgical eyes exhibited slight hyperemia of
the  conjunctiva,  reversible  edema  of  the  cornea,  and
measurable flare and cells in the anterior chamber, which all
resolved  within  the  first  week  post-surgery.  The  mean
endothelial  cell  density  measured  1  month  after  surgery
decreased slightly compared with preoperative values, but this
Figure  2.  The  inhibition  effect  of
IKKβ-siRNA  on  the  proliferation  of
monkey Tenon’s fibroblasts. Data are
presented  as  the  percentage  of  viable
cells  compared  with  the  untreated
(control)  cells  (mean±SD,  n=6).  An
asterisk indicates that p<0.05.
TABLE 1. THE MEAN ENDOTHELIAL CELL DENSITY (MEAN±SD) BEFORE AND AFTER SURGERY.
Group siRNA group PBS group MMC group
Presurgery 3,498±338 3,434±642 3,453±418
Postsurgery 3,388±150 3,362±499 3,209±146
p=0.343 p=0.594 p=0.291
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2505change was not statistically significant in all groups (Table 1).
In  the  experimental  group,  repeated  subconjunctival
injections  of  CS-g-(PEI-b-mPEG)/IKKβ-siRNA  were  well
tolerated  in  the  monkeys.  There  were  no  remarkable
differences  in  ocular  findings  between  the  control  and
experimental groups. Superficial punctuate keratitis occurred
in 1 eye of the MMC treated group. Not one case of bleb leaks
or endophthalmitis was observed.
Bleb survival and characteristics—IKKβ-siRNA and
MMC groups significantly prolonged bleb survival compared
with the PBS group in the monkey model (log rank test;
X2=11.548, p<0.01), as shown in the Kaplan–Meier survival
curve in Figure 3A. The medians for survival days were: 45.5,
60,  and  29.5  in  the  siRNA,  MMC,  and  PBS  groups,
respectively.
Height and area of the blebs in the surgical eyes were
compared among the groups. Eyes in the siRNA and MMC
groups had significantly higher and larger blebs than the PBS
group  (F=97.947  and  34.364,  respectively,  both  p<0.01;
Figure 3B,C). The blebs in the MMC group were higher than
blebs  in  the  siRNA  group  (p<0.01),  while  there  was  no
significant difference in the area of the blebs between two
groups (p=0.214). Figure 4 depicted the typical appearance of
the blebs post-surgery in the three groups. MMC treated eyes
were associated with typical avascular blebs surrounded by a
local conjunctival hyperemia. Subconjunctival injection of
IKKβ-siRNA, however, resulted in a relatively less elevated
bleb and a normal-appearing conjunctiva.
Intraocular  pressure—Table  2  and  Figure  5  both
illustrated the IOP change after filtration surgery among the
three groups. Before the surgery, there was no significant
difference in the baseline IOP (F=0.284, p=0.758). A steep
reduction  in  IOP  was  observed  in  the  early  stages  after
surgery. Thereafter, IOP gradually increased in all groups.
Although there was a trend toward decreases in IOPs for eyes
treated with siRNA and MMC on the designated days after
surgery,  these  data  were  variable  and  not  significantly
different from those of eyes treated with PBS (all p>0.05).
Histologic examination—The histological sections of
the  surgical  sites  were  examined  at  the  end  of  the
postoperative  period.  Eyes  treated  with  PBS  exhibited
massive fibrosis, and were accompanied by nearly complete
scarring over the sclerostomy site (Figure 6A). In contrast,
eyes  treated  with  siRNA  showed  a  marked  reduction  in
subconjunctival  scar  tissue  (Figure  6B).  The  conjunctival
epithelium appeared healthy, and the subepithelial connective
tissue was loosely arranged and had moderate subconjunctival
cavities.  As  expected,  eyes  treated  with  MMC  exhibited
marked acellularity and large bleb cavities (Figure 6C). The
thinning of the conjunctiva and Tenon’s layer were present in
the region of the surgery.
DISCUSSION
Glaucoma  filtration  surgery  often  fails  due  to  excessive
scarring, which occurs during the wound healing process. The
perioperative  administration  of  antimetabolites  has
significantly improved the success rate of filtration surgery.
However, they are associated with an increased incidence of
sight-threatening  complications,  such  as  bleb  leaks  and
endophthalmitis [2-4]. These problems have stimulated the
search for new agents to minimize ocular complications.
Since  the  discovery  of  NF-κB  in  1986,  inappropriate
activation of NF-κB is thought to be linked to a great variety
of diseases and pathological states, including tissue injury,
inflammation, and repair [5,8]. As IKK integrates many NF-
κB-activating  pathways,  the  most  effective  and  specific
approach to the modulation of NF-κB activity may result from
IKK inhibitors [9]. In a previous study [12], the inhibiting
effects of NF-κB blocking by IKKβ-siRNA on the cultured
human Tenon’s fibroblasts were determined. We extend the
investigation of IKKβ-siRNA in a non-human primate model
of glaucoma surgery in the current study. Because of the
highly  specific  nature  of  RNA  interference,  we  first  re-
Figure 3. The effects of IKKβ-siRNA, MMC, and PBS on bleb survival, bleb height, and bleb area. A: IKKβ-siRNA (n=6) and MMC (n=4)
groups significantly prolonged bleb survival compared with the PBS group (n=4) in the monkey model (log rank test; p<0.01), as shown in
the Kaplan-Meier survival curve. B: Higher blebs were observed in the siRNA group than in the PBS group (p<0.01), while the MMC group
showed the highest blebs among the three groups (p<0.01). C: Eyes in the siRNA and MMC groups had significantly larger bleb area compared
with the PBS group (p<0.01), but there was no significant difference between the siRNA and MMC groups (p=0.214).
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2506designed  and  screened  the  highly  effective  IKKβ-siRNA,
based on the coding sequence of the Macaca mulatta IKKβ
gene. The in vitro results showed that the inhibiting effects
were  dose-dependent  and  reached  a  plateau  at  the
concentration of 50 nM. Previous studies have reported that
the  duration  of  siRNA  induced  silencing  may  last
approximately  5–7  days,  and  wound  healing  at  the
sclerectomy site by proliferating fibroblasts occurs within the
first  14  postoperative  days  [13,14].  Therefore,  we  used
subconjunctival injection of 50 nM concentration of IKKβ-
siRNA into the bleb area at the time of surgery, and repeated
injection on day 7 post surgery in the present study.
The results indicated that the IKKβ-siRNA treated eyes
exhibited prolonged bleb survival and delayed increase of IOP
postoperatively compared with PBS control eyes. Histologic
analysis of the surgical sites also showed that both IKKβ-
siRNA  and  MMC  prevented  fibrosis,  but  IKKβ-siRNA
treated eyes appeared less destructive to local tissue. The
mechanism  of  IKKβ-siRNA  preventing  fibrosis  may  be
related  to  the  inhibitory  effect  of  NF-κB  blocking  on
inflammation and the proliferation of Tenon’s fibroblasts.
Other studies have also reported that the inhibition of NF-kB
using IKKβ inhibitors ameliorated the pathogenesis in many
fibrotic  diseases,  including  lung  fibrosis  [15-17],  hepatic
fibrosis [18,19], and skin proliferative disorders [20,21]. On
the other hand, NF-κB signaling occurs through either the
classical  (canonical)  or  the  alternative  (non-canonical)
pathway.  Whereas  classical  NF-κB  activation  is  IKKβ
Figure 4. Figure 4. Representative bleb photographs after surgery. A-C: siRNA group, D-F: MMC group, G-I: PBS group, on day 3, day 21,
and day 49, respectively. Treatment with IKKβ-siRNA was associated with an elevated, diffuse, fleshy-looking bleb compared with the flat,
scarred bleb in the PBS group (day21 and day 49). MMC treated eyes were associated with typical avascular cystic blebs surrounded by local
conjunctival hyperemia while IKKβ-siRNA resulted in a relatively less-elevated bleb and a normal-appearing conjunctiva.
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2507dependent  and  closely  linked  to  the  orchestration  of
inflammatory responses, the alternative pathway depends on
IKKα homodimers and NF-κB inducing kinase (NIK), and it
is particularly important for B-cell maturation and immune
responses  [22].  Since  NF-κB  is  also  involved  in  normal
cellular physiology, global inhibition of NF-κB may result in
profound side effects, such as the apoptosis of healthy cells.
However, selective suppression of inflammation-induced NF-
κB  activity  by  IKΚβ-siRNA  may  leave  some  NF-κB-
dependent signaling and is beneficial for wound modulation
[9,22]. We propose this is the reason for the more effective
tissue preservation of IKKβ-siRNA than that of MMC. This
also may be one of the reasons that the inhibitory effect of
IKKβ-siRNA  did  not  increase  when  the  concentration  of
IKKβ-siRNA was increased more than 50 nM in vitro in our
study (another reason may be due to the limitation of the
efficiency of transfection). This novel approach, based on
both  the  IKKβ-dependent  NF-κB  pathway  and  RNAi
technology, may potentially be a more controlled alternative
as an anti-scarring agent in glaucoma filtration surgery.
TABLE 2. SUMMARY TABLE OF THE MEAN IOPS (MMHG±SD) IN EACH GROUP BEFORE AND AFTER SURGERY.
Days after surgery PBS group siRNA group MMC group
0 13.58±1.67 14.22±2.77 14.83±2.14
3 7.10±1.45 6.12±1.00 6.00±1.15
7 7.33±1.04 7.58±2.78 6.50±0.58
10 8.90±3.44 7.13±2.11 6.85±0.98
14 10.08±4.19 8.90±1.07 6.75±0.96
17 10.00±2.53 9.33±0.90 7.63±1.30
21 9.43±2.00 9.55±1.22 8.48±1.09
24 9.35±1.51 9.57±1.11 8.33±1.04
28 10.18±1.82 9.62±1.23 7.98±1.04
31 10.78±3.10 10.08±1.80 8.65±1.11
35 11.33±2.85 10.43±1.93 8.38±1.53
42 11.00±2.31 9.90±2.21 8.90±2.04
49 11.90±3.50 11.60±0.69 9.10±2.16
56 11.85±2.81 11.75±1.22 10.08±2.43
60 13.25±2.04 11.90±1.24 10.43±2.45
Figure 5. The effects of IKKβ-siRNA,
MMC, and PBS on postoperative IOPs.
There were no significant differences in
IOP readings among the three groups on
the designated days after surgery (n=6,
n=4, and n=4, respectively, all p>0.05).
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2508The  eye  is  a  relatively  isolated  compartment,  which
makes it an ideal target organ for gene therapy [23]. The main
advantage of RNAi is its ability to silence the expression of
deleterious genes of known sequence. There has been rapid
progress toward its use as a therapeutic modality since its first
description less than a decade ago. Nakamura et al. [24] and
Wang et al. [25] have already reported improved outcomes of
glaucoma surgery in animal models using RNAi technologies.
Both of the studies used viral vectors to deliver the gene of
interest. Although having the advantage of high transfection
efficacy,  the  use  of  viral  delivery  systems  is  limited  by
endogenous  recombination  and  host  immunity  [26].
Moreover, since ontogenesis and mortality have been reported
[27], concerns have been raised regarding the safety of using
viral vectors in gene therapy trials in humans. In this study,
we  used  a  novel  biodegradable  copolymer,  CS-g-(PEI-b-
mPEG) as the vector. The in vitro results have indicated that
CS-g-(PEI-b-mPEG)  featured  good  biocompatibility  and
transfection efficiency. Subconjunctival IKKβ-siRNA/CS-g-
(PEI-b-mPEG)  application  in  the  animal  model  appeared
clinically safe and well tolerated within the experimental time.
Furthermore,  it  has  been  proposed  that  the  hydrophobic
domains  in  the  CS-g-(PEI-b-mPEG)  may  be  capable  of
storing hydrophobic drugs and allowing a slow and sustained
release [28], which may reduce both the need for frequent
applications and toxic ocular side effects.
In this study no significant differences were detected in
IOP among the three groups. There are questions about the
usefulness of IOP as a measure of successful filtration surgery
and bleb function in the animal model. Several investigations
with the normotensive model failed to find the IOP changes
after antiproliferative treatments, in spite of effects detected
on the bleb morphologic characteristics [29-31]. Therefore,
bleb survival rather than IOP was used as the primary outcome
measure in the current study [30,31].
In  summary,  the  current  study  demonstrated  that
inhibition of NF-κB activity by local application of IKKβ-
siRNA  improved  the  surgical  outcome  in  a  non-human
primate model of glaucoma filtration surgery. Further studies
are  needed  to  improve  the  application  methods,  and  to
investigate the long-term effects and safety of this novel anti-
scarring agent.
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